Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Pardridge, William M
2001.
BBB-Genomics: creating new openings for brain-drug targeting.
Drug Discovery Today,
Vol. 6,
Issue. 8,
p.
381.
Shi, Ningya
Zhang, Yun
Zhu, Chunni
Boado, Ruben J.
and
Pardridge, William M.
2001.
Brain-specific expression of an exogenous gene after i.v. administration.
Proceedings of the National Academy of Sciences,
Vol. 98,
Issue. 22,
p.
12754.
Drin, Guillaume
Rousselle, Christophe
Scherrmann, Jean-Michel
Rees, Anthony R
and
Temsamani, Jamal
2002.
Peptide delivery to the brain via adsorptive-mediated endocytosis: Advances with SynB vectors.
AAPS PharmSci,
Vol. 4,
Issue. 4,
p.
61.
Lee, Hwa Jeong
Zhang, Yun
Zhu, Chunni
Duff, Karen
and
Pardridge, William M.
2002.
Imaging Brain Amyloid of Alzheimer Diseasein Vivoin Transgenic Mice with an Aβ Peptide Radiopharmaceutical.
Journal of Cerebral Blood Flow & Metabolism,
Vol. 22,
Issue. 2,
p.
223.
Shusta, Eric V.
Boado, Ruben J.
Mathern, Gary W.
and
Pardridge, William M.
2002.
Vascular Genomics of the Human Brain.
Journal of Cerebral Blood Flow & Metabolism,
Vol. 22,
Issue. 3,
p.
245.
Song, Bi-Wei
Vinters, Harry V.
Wu, Dafang
and
Pardridge, William M.
2002.
Enhanced Neuroprotective Effects of Basic Fibroblast Growth Factor in Regional Brain Ischemia after Conjugation to a Blood-Brain Barrier Delivery Vector.
Journal of Pharmacology and Experimental Therapeutics,
Vol. 301,
Issue. 2,
p.
605.
Pardridge, William M.
2002.
Drug and gene targeting to the brain with molecular trojan horses.
Nature Reviews Drug Discovery,
Vol. 1,
Issue. 2,
p.
131.
Liu, Gang
Men, Ping
Perry, George
and
Smith, Mark A.
2003.
Nanotechnologies for the Life Sciences.
O'Kane, Robyn L.
and
Hawkins, Richard A.
2003.
Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier.
American Journal of Physiology-Endocrinology and Metabolism,
Vol. 285,
Issue. 6,
p.
E1167.
Chen, Qingqi
Sowa, Damian A.
Cai, Jianlin
and
Gabathuler, Reinhard
2003.
Efficient One-Pot Synthesis of Doxorubicin Conjugates Through Its Amino Group to Melanotransferrin P97.
Synthetic Communications,
Vol. 33,
Issue. 14,
p.
2401.
Boado, Ruben J.
and
Pardridge, William M.
2003.
Imaging gene expression in the brain with peptide nucleic acid (PNA) antisense radiopharmaceuticals and drug targeting technology.
International Journal of Peptide Research and Therapeutics,
Vol. 10,
Issue. 3-4,
p.
169.
Pardridge, William M.
2003.
Molecular and Cellular Biology of Neuroprotection in the CNS.
Vol. 513,
Issue. ,
p.
397.
Pawar, R.
Avramoff, A.
and
Domb, A. J.
2003.
Nanotechnologies for the Life Sciences.
Kroenke, Christopher D.
and
Neil, Jeffrey J.
2004.
Use of magnetic resonance to measure molecular diffusion within the brain extracellular space.
Neurochemistry International,
Vol. 45,
Issue. 4,
p.
561.
Black, Keith L.
and
Ningaraj, Nagendra S.
2004.
Modulation of Brain Tumor Capillaries for Enhanced Drug Delivery Selectively to Brain Tumor.
Cancer Control,
Vol. 11,
Issue. 3,
p.
165.
Chen, Qingqi
and
Gabathuler, Reinhard
2004.
Synthesis of Camptothecin Melantotransferrin (p97) Conjugate Through a Carbamate Bond.
Synthetic Communications,
Vol. 34,
Issue. 13,
p.
2415.
Cho, Steve Y.
and
Fine, Howard A.
2004.
Handbook of Anticancer Pharmacokinetics and Pharmacodynamics.
p.
373.
Das, Debanjan
and
Lin, Senshang
2005.
Double-Coated Poly (Butylcynanoacrylate) Nanoparticulate Delivery Systems for Brain Targeting of Dalargin Via Oral Administration.
Journal of Pharmaceutical Sciences,
Vol. 94,
Issue. 6,
p.
1343.
Pardridge, William M.
2005.
The blood-brain barrier: Bottleneck in brain drug development.
NeuroRX,
Vol. 2,
Issue. 1,
p.
3.
Olivier, Jean-Christophe
2005.
Drug transport to brain with targeted nanoparticles.
NeuroRX,
Vol. 2,
Issue. 1,
p.
108.